KNOXYL
Knoxyl
A localised therapeutic approach for treatment of glioblastoma.
Knoxyl is MTL-004 formulated with a bioresorbable paste which is applied directly to the tumour resection bed following surgery.
HOW KNOXYL WORKS
Knoxyl is applied directly to the tumour resection cavity at the end of surgery. The bioresorbable paste conforms to the irregular surfaces at the cavity, maintaining excellent contact with the tumour margin and delivering sustained local activity as it gradually resorbs over time.
SAFETY PROFILE
FUTURE POTENTIAL
Following the successful transfer of Knoxyl into the clinic, Gordian plans to evaluate MTL-004 in additional solid tumour indications such as bladder cancer, where localised treatment may provide clinical benefits by controlling post resection tumour recurrence.
Bladder Cancer
Other solid tumours
Broad Potential
One platform, multiple applications